Respiratory Virus Toolkit
Prevalence of A baumannii and C auris in Patients Receiving Mechanical Ventilation
Ending the COVID-19 emergency and transitioning from emergency phase to longer-term disease management: guidance on calibrating the response, 4 September 2023
Zika virus disease
Treating malaria
Ebola and Marburg diseases screening and treatment center design
Communicable disease threats report, 2-8 July 2023, week 27
Increasing risk of mosquito-borne diseases in EU/EEA following spread of Aedes species
Sexual Health (HIV content only) elearning Course - eIntegrity
Maternal and Neonatal Deterioration - elearning for healthcare
Core Anaesthesia Training : eIntegrity eLearning Courses
Marburg virus disease outbreak in Equatorial Guinea
Notes from the Field: Rift Valley Fever Outbreak — ...
Summer Could Bring a Surge of New Mpox Cases
A New Antiviral Option for CMV Prevention After Kidney Transplant
Interim Guidance for Clinicians on Human Infections with Variant Flu
Marburg virus disease - the United Republic of Tanzania
International Exchange Study Visit for improved and Strengthened Antimicrobial Resistance Surveillance System in Africa – Africa CDC
Outbreak of suspected fungal meningitis associated with surgical procedures performed under spinal anaesthesia – the United States of America and Mexico
Africa Collaborative Initiative to Advance Diagnostics – Africa CDC
WHO announces the development of the Consolidated Guidelines on STI prevention and care (2022-2023)
NIH study identifies features of Long COVID neurological symptoms
Drugs to prevent COVID-19: living guideline
The health workforce crisis in Europe is no longer a looming threat – it is here and now. The Bucharest Declaration charts a way forward
Covid-19: Evusheld is unlikely to prevent infection with current or future variants, NICE concludes
Protocol for point prevalence surveys of healthcare-associated infections and antimicrobial use in European long-term care facilities – version 4.0
NIH trial to evaluate Shionogi antiviral in adults hospitalized with COVID-19
Point prevalence survey of healthcare-associated infections and antimicrobial use in European long-term care facilities 2016–2017
Laboratory-Confirmed COVID-19 Case Incidence Rates ...
COVID-19 Symptoms 6 Months After Onset and the Role of Vaccination for SARS-CoV-2 Infection
How are covid-19 symptoms changing?
Most long covid effects resolve within a year after mild infection | BMJ
Guide for clinicians evaluating an ill person for Ebola disease | Evaluating Patients | Clinicians | Ebola (Ebola Virus Disease) | CDC
Rapid recommendation: A living WHO guideline on drugs for covid-19
WHO updates COVID-19 guidelines on masks, treatments and patient care
Clinical management of COVID-19: Living guideline, 13 January 2023
Therapeutics and COVID-19: Living guideline, 13 January 2023
Safety and monitoring for patients receiving Nirmatrelvir-ritonavir for COVID-19
Administration of Nirmatrelvir-ritonavir for COVID-19
Nirmatrelvir-ritonavir for COVID-19
Infection Prevention and Control Recommendations for Hospitalized Patients Under Investigation (PUIs) for Ebola Virus Disease (EVD) in U.S. Hospitals | Ebola Virus Disease | Clinicians | Ebola (Ebola Virus Disease) | CDC
Latest data on respiratory infections in Scotland - News - Public Health Scotland
Mpox - Clinical Quick Reference
Protecting the workforce through influenza and COVID-19 vaccination: perspectives from Greece
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 11 December 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Cholera Outbreaks: Emergency Preparedness and Response
The Mpox Vaccine (JYNNEOS Vaccine) | Monkeypox | Poxvirus | CDC
Notes from the Field: Clinical and Epidemiologic Characteristics of Mpox Cases from the Initial Phase of the Outbreak — New York City, May 19–July 15, 2022 | MMWR
Training on handling, storing and transporting Pfizer-BioNTech COVID-19 mRNA Vaccine COMIRNATY® (Tozinameran)
Technical guidance
Case management
Covid-19: Molnupiravir does not cut hospital admissions or deaths in vaccinated people at high risk, trial finds
COVID-19 Resources – Africa CDC
Resources – Africa CDC
Nursing Home COVID-19 Vaccination Data Dashboard | NHSN | CDC
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 27 November 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Poliomyelitis (Polio) and Acute Flaccid Paralysis | Public Health Ontario
Long Term Care Facilities Enrolling in CDC COVID-19 Vaccination Program | CDC
Mask and outbreak guidance updated in care settings
ECDC organises epidemic intelligence and rapid risk assessment training in Armenia
Moving WHO guidance on antibiotics into the heart of clinical practice
Mpox Toolkit for Correctional and Detention Facilities
Chikungunya fact sheet
UKHSA publishes strategy outlining plans to eliminate mpox transmission
Health-care associated infection surveillance
Types of Influenza Viruses
Vaccine Glossary of Terms | CDC
Chemical and Biological Deliberate Events
Prevention, identification and management of infections in health workers in the context of COVID-19
Interim Guidance for Influenza Outbreak Management in Long-Term Care and Post-Acute Care Facilities | CDC
Testing & Management Flu and SARS-COV-2 in Nursing Homes
COVID-19 NMA Summary Report
Together We Can Improve How We Use Antibiotics and Antifungals | TATFAR | Antibiotic/Antimicrobial Resistance | CDC
Paxlovid Associated with Decreased COVID-19 Hospitalizations ..
European Antibiotic Awareness Day 2022 - launch event
Interim analysis of COVID-19 vaccine effectiveness in healthcare workers, an ECDC multi-country study, May 2021–July 2022
ASPHER - ASPHER Climate Action through Public Health Education & Training
Monkeypox: a detailed profile of the disease
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 23 October 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Covid-19: NICE rejects five treatments over uncertain evidence and price in draft guidance
COVID-19 Clinical Care Pathway
Priorities for Hospital Core Element Implementation | Antibiotic Use | CDC
COVID-19–Associated Hospitalizations Among U.S. Infants Aged <6 Months — COVID-NET, 13 States, June 2021–August 2022
Cleaning and Disinfecting Your Facility
US faces triple epidemic of flu, RSV, and covid
Fiji leads the way on climate-resilient and environmentally-sustainable healthcare facilities
Evidence for "substantial" monkeypox transmission before symptoms | BMJ
Severe Monkeypox in Hospitalized Patients — United ...
Monkeypox – Africa CDC
How It Spreads | Monkeypox | Poxvirus | CDC
Introduction to Nipah virus disease | OpenWHO
WHO announces the update of the Consolidated Guidelines on HIV Testing Services (update 2022–23)
Intervention Services for People with or Exposed to Monkeypox | Monkeypox | Poxvirus | CDC
Science Brief: Detection and Transmission of Monkeypox Virus | Monkeypox | Poxvirus | CDC
Ebola PPE Frequently Asked Questions | Personal Protective Equipment (PPE) | Public Health Planners | Ebola (Ebola Virus Disease) | CDC
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 25 September 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Ocular Monkeypox — United States, July–September 2022 | MMWR
WHO's Infodemic Management live! Online storytelling event
Global antimicrobial resistance (AMR) research agenda in human health: a call for expert contributions
Monkeypox Considerations for Sexual Health Services | 2022 | Dear Colleague Letters | NCHHSTP | CDC
Monkeypox treatment trial begins in the Democratic Republic of the Congo | National Institutes of Health (NIH)
Covid-19: Hospital admissions rise in England as some trusts reinstate mask requirements | The BMJ
Drug-resistant tuberculosis treatment | OpenWHO
Interim Clinical Considerations for Management of Ocular Monkeypox Virus Infection | Monkeypox | Poxvirus | CDC
Delivering quality health services to refugees and migrants from Ukraine
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 11 September 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
CDC - Malaria - Diagnosis & Treatment (United States) - Treatment (U.S.) - Guidelines for Clinicians
Therapeutics and COVID-19: Living guideline, 16 September 2022
WHO announces updates to its guidelines on tests for the diagnosis of TB infection
WHO consolidated guidelines on tuberculosis: module 3: diagnosis: tests for TB infection
Safety and side effects - COVID-19 vaccine information and resources - COVID-19 vaccinations - COVID-19 - Conditions and diseases - Our areas of work - Public Health Scotland
Monkeypox in a Young Infant — Florida, 2022 | MMWR
National protocol for Comirnaty® Original/Omicron BA.1 (15/15 micrograms)/dose COVID-19 mRNA vaccine - GOV.UK
Health Care Personnel Exposures to Subsequently Laboratory-Confirmed Monkeypox Patients — Colorado, 2022 | MMWR
Opening Remarks by Dr. Stuart Minchin, Director-General of the Pacific Community at the Inaugural Pacific Disaster Risk Reduction Ministers Meeting | The Pacific Community
Seasonal Influenza Vaccine Safety: A Summary for Clinicians | CDC
Children and Flu Antiviral Drugs | CDC
WHO strongly advises against antibody treatments for covid-19 patients | BMJ
Call for Expression of Interest: Rapid (Scoping) Review of Trust in Science in Public Health Emergencies
Training Workshop in Risk Communication
EPI-WIN webinar: Managing stigma and discrimination in health care settings in public health emergencies such as monkeypox
Monkeypox Collection
COVID-19 - information and guidance for social, community and residential care settings - version 2.3 - COVID-19 - information and guidance for social, community and residential care settings - Publications - Public Health Scotland
Clinical Considerations for Pain Management of Monkeypox | Monkeypox | Poxvirus | CDC
Clinical management of COVID-19: Living guideline, 15 September 2022
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 21 August 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
FAQs on Reporting COVID-19 Vaccination Data | NHSN | CDC
Improving risk communication in public health crises: Interview with Dr Savoia, speaker at ECDC's risk communication workshop
Six emergency management courses recognized for high-quality learning
Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022 | MMWR
Infection prevention and antimicrobial stewardship - the role of nurses in preventing AMR
MR Lab Network
CDC Monkeypox Response Leadership Update | 2022 | Dear Colleague Letters | NCHHSTP | CDC
Antiviral Drugs for Seasonal Influenza: Additional Links and Resources | CDC
Multidrug-Resistant Strain of Salmonella Newport | Salmonella | CDC
Priorities, actions and technical support of the IPC pillar of the regional COVID-19 Incident Management Support Team
World Antimicrobial Awareness Week 2022
Training and tools
SARS-CoV-2 antigen levels linked to patient outcomes | National Institutes of Health (NIH)
The COVID-19 Risk Communication Package For Healthcare Facilities
Influenza (Flu) Vaccine Safety | CDC
WHO Academy offers virtual course on acute respiratory infection
Generic protocol for COVID-19 vaccine effectiveness studies at long-term care facilities in the EU/EEA
Report of a WHO expert consultation on dosing to enable implementation of treatment recommendations in the WHO consolidated guidelines on the management of TB in children and adolescents
What People Who Raise Pigs Need To Know About Influenza (Flu) | CDC
Monkeypox
Polio Investigation Information for Clinicians | CDC
Covid-19: Results from India's 12 molnupiravir clinical trials remain unpublished | The BMJ
Resources for health professionals on monkeypox
WHO makes new recommendations for Ebola treatments, calls for improved access
Transition of COVID-19 Hospital Reporting | NHSN | CDC
Clinical characteristics of COVID-19
Covid-19: UK will not buy Evusheld owing to "insufficient data" on protection, government says | The BMJ
COVID-19: the green book, chapter 14a - GOV.UK
WHO R&D Blueprint for Epidemics
Monkeypox (MPX) Overview for Disease Intervention Specialists (DIS) and Others Providing Intervention Services to People with or Exposed to MPX | Monkeypox | Poxvirus | CDC
Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection — United States, August 2022 | MMWR
Clinical management of COVID-19
Pathogen Reduction & Decolonization | CDC
Monkeypox Living Evidence Profile - Canada.ca
Epidemiologic and Clinical Characteristics of Monkeypox Cases — United States, May 17–July 22, 2022 | MMWR
Management of critical COVID-19 Advanced non-invasive respiratory support: high-flow nasal oxygen and non-invasive ventilation- Part 2
Management of critical COVID-19: Acute hypoxaemic respiratory failure and COVID-19
Influenza Hospitalization Surveillance Network (FluSurv-NET) | CDC
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 10 July 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Covid-19: Ontario hospitals close wards as nursing shortage bites | The BMJ
Reporting form for AEFI
COVID-19: guidance for health professionals - GOV.UK
WHO publishes new guidelines on HIV, hepatitis and STIs for key populations
Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations
WHO recommends long-acting cabotegravir for HIV prevention
Guidelines on long-acting injectable cabotegravir for HIV prevention
Malaria chemoprevention efficacy study protocol
Differentiated and simplified pre-exposure prophylaxis for HIV prevention: update to WHO implementation guidance
Good practices guidance handbook for national TB surveys: how to apply good clinical and good data management practices for national TB surveys
Monkeypox: New clinical symptoms are identified in confirmed cases | The BMJ
Clinical Considerations for Monkeypox in People Who are Pregnant or Breastfeeding | Monkeypox | Poxvirus | CDC
Monkeypox: semen testing for viral DNA - GOV.UK
Rapid Diagnostic Testing for Response to the Monkeypox Outbreak — Laboratory Response Network, United States, May 17–June 30, 2022 | MMWR
Frequently Asked Questions | Monkeypox | Poxvirus | CDC
CDC's Response to the 2022 Monkeypox Outbreak | Monkeypox | Poxvirus | CDC
What Healthcare Professionals Should Know | Monkeypox | Poxvirus | CDC
Treatment Information for Healthcare Professionals | Monkeypox | Poxvirus | CDC
The WHO Global Clinical Platform for monkeypox
Vaccines and immunization for monkeypox: Interim guidance, 14 June 2022
Monkeypox Virus | Public Health Ontario
Monkeypox outbreak 2022 - Global
Monkeypox minimum dataset case reporting form (CRF)
Clinician FAQs | Monkeypox | Poxvirus | CDC
Principles for monkeypox control in the UK: 4 nations consensus statement - GOV.UK
Prevention | Monkeypox | Poxvirus | CDC
De-isolation and discharge of monkeypox-infected patients: interim guidance - GOV.UK
Monkeypox: case definitions - GOV.UK
Infection Control: Healthcare Settings | Monkeypox | Poxvirus | CDC
Case Definition† | Monkeypox | Poxvirus | CDC
Monkeypox - GOV.UK
Emergency care plan is "inadequate" on every level, say doctors | The BMJ
NHS to rollout two new drugs to tackle superbugs | The BMJ
Covid-19: Two million people in the UK are estimated to be experiencing long covid, says ONS | The BMJ
Covid-19: JCVI advises further booster for vulnerable adults and health and care workers | The BMJ
Covid-19: UK adds sore throat, headache, fatigue, and six other symptoms to official list | The BMJ
Personal Protective Equipment (PPE) portal - GOV.UK
WHO Drug Information - Volume 36, No. 2
COVID-19 Vaccines for Long-term Care Residents | CDC
The WHO Global Clinical Platform for COVID-19
Enhanced Surveillance of Antimicrobial-Resistant Gonorrhea in Canada (infographic) - Canada.ca
COVID-19 Reverses Progress in Fight Against Antimicrobial Resistance in U.S. | CDC Online Newsroom | CDC
COVID-19 - guidance for health protection teams (HPTs) - version 2.4 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
WHO announces updates on its guidance on tuberculosis care and support
WHO consolidated guidelines on tuberculosis: module 4: treatment: tuberculosis care and support
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
Interim guidance on the use of rapid antigen detection tests for the identification of SARS-CoV-2 infection - Canada.ca
Changes to the severity of COVID-19 and impact on hospitals in Scotland, January-April 2022 - Changes to the severity of COVID-19 and impact on hospitals in Scotland - Publications - Public Health Scotland
Understanding and using WHO guidelines on tuberculosis | OpenWHO
Clinical management of COVID-19: Living guideline, 23 June 2022
Immediate actions in response to detection of vaccine derived polio virus type 2 (VDPV2) in London sewage samples - GOV.UK
Report from the scoping consultation on severe bacterial infections among people with advanced HIV disease
Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment — California, December 2021–May 2022 | MMWR
COVID-19 - guidance for health protection teams (HPTs) - version 2.3 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
Infection prevention and control (IPC) educational resources - COVID-19 health protection guidance - COVID-19 - Our areas of work - Public Health Scotland
Notes from the Field: COVID-19–Associated Mortality Risk Among Long-Term Care Facility Residents and Community-Dwelling Adults Aged ≥65 Years — Illinois, December 2020 and January 2022 | MMWR
Global Clinical Platform
Trends in Acute Hepatitis of Unspecified Etiology and Adenovirus Stool Testing Results in Children — United States, 2017–2022 | MMWR
COVID-19 Case Management Webinar Series: Care of the critical patient
Disease surveillance reports
World Health Organization WHO emergency preparedness
Malaria Elimination | OpenWHO
Questions and answers on COVID-19: Current situation in the EU
WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia
Maintaining infection prevention and control measures for COVID-19 in health care facilities: Policy brief, 7 June 2022
Severity of disease associated with Omicron variant as compared with Delta variant in hospitalized patients with suspected or confirmed SARS-CoV-2 infection
Infection Prevention and Control Assessment Tool for Nursing Homes Preparing for COVID-19 | HAI | CDC
Guidance for diagnostic testing of cases with severe acute hepatitis of unknown aetiology in children
Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021 | MMWR
Global report on infection prevention and control
COVID-19: epidemiology, virology and clinical features - GOV.UK
Manual for selection of molecular WHO recommended rapid diagnostic tests for detection of tuberculosis and drug-resistant tuberculosis
Practical manual of processing stool samples for diagnosis of childhood TB
European COVID-19 surveillance network (ECOVID-Net)
Clinical Guidance for Adenovirus Testing and Typing of Patients Under Investigation | CDC
Rapid communication: Key changes to the treatment of drug-resistant tuberculosis
The WHO Essential Medicines List Antibiotic Book: infographics
Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 20 March 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
COVID-19 treatments - Canada.ca
Societal Experts Action Network: Strategies for Communicating with People Who Are Not Vaccinated to Build Confidence in Covid-19 Vaccines | The National Academies Press
Health Canada authorizes Evusheld for the prevention of COVID-19 in immune compromised adults and children - Canada.ca
COVID-19 Emergency ICD Codes
Reading: The Future of Nursing 2020-2030: Charting a Path to Achieve Health Equity |The National Academies Press
WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Susceptible Tuberculosis Treatment
Malaria: The malaria vaccine implementation programme (MVIP)
WHO Webinar Series to Support Implementation of National Action Plans on Antimicrobial Resistance
Clinical care of severe acute respiratory infections – Tool kit
Core competencies in applied disease epidemiology in Europe: facilitating collaboration and the use of a common language among professionals
Statement from the Council of Chief Medical Officers of Health (CCMOH) on the importance of staying up to date with COVID-19 vaccines - Canada.ca
WHO announces updates on new TB antigen-based skin tests for the diagnosis of TB infection
The Janssen COVID-19 Vaccine's Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events | CDC
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
What Clinicians Need to Know About Pfizer-BioNTech COVID-19 Vaccination of Adolescents
Explore the indicators
WHO Policy Guidance on Integrated Antimicrobial Stewardship Activities
Toward a National Health Care Survey: A Data System for the 21st Century |The National Academies Press
Strengthening collaboration on Health Technology Assessment
An Introduction to Digital Clinical Safety
Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis — United States, 2022
Pediatric Emergency Department Visits Before and During the COVID-19 Pandemic — United States, January 2019–January 2022
Armenia to host WHO Emergency Medical Teams (EMT) Global Meeting 2022
Communicating risk in public health emergencies
Human Infection with Avian Influenza A Virus: Information for Health Professionals and Laboratorians | Avian Influenza (Flu)
Antimicrobial stewardship programmes in health-care facilities in low-
Estimated number of incident tuberculosis cases
Hepatitis B Questions and Answers for Health Professionals | CDC
Types of drug-resistant TB
COVID-19 - information and guidance for social, community and residential care settings - version 2.1 - COVID-19 - information and guidance for social, community and residential care settings - Publications - Public Health Scotland
Weekly national seasonal respiratory report - Week 18 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland
Building the Workforce We Need to Care for People with Serious Illness: Proceedings of a Workshop |The National Academies Press
Slide Decks on HIV Screening, Prevention, and Treatment and Care
Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 27 February 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Tuberculosis — United States, 2021 | MMWR
Health Communications Science Digest - April | Gateway to Health Communication | CDC
Tuberculosis in the time of COVID-19
Therapeutics and COVID-19: living guideline
WHO Global Initiative for Emergency and Essential Surgical Care (GIEESC)
Global research on coronavirus disease (COVID-19)
WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator
Pfizer-BioNTech COVID-19 Vaccine Overview and Safety | CDC
COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022 | MMWR
Interim Guidance on the Use of Antiviral Medications for Treatment of Human Infections with Novel Influenza A Viruses Associated with Severe Human Disease | Avian Influenza (Flu)
Acute hepatitis: technical briefing - GOV.UK
Mitigating the COVID-19 outbreak through global data sharing
Technological hazards and health risks in Ukraine
Global Competency and Outcomes Framework for Universal Health Coverage
Hospital Preparedness for Epidemics
Diagnostic testing and screening for SARS-CoV-2
Open to all, anytime, anywhere: Free online courses bring vaccine knowledge to the global community
Infection prevention and control in adult social care: COVID-19 supplement
COVID-19 Resource Centre
CDC NERD Academy Promotional Flyer
Science Ambassador Fellowship - Glossary
COVID-19 respiratory equipment
Tuberculosis preventive treatment
Public-Use Data Files and Documentation
State of the world's nursing 2020: investing in education, jobs and leadership
State of the world's nursing 2020: investing in education, jobs and leadership (Annex)
Health workforce governance and leadership capacity in the African Region Review of human resources for health units in the ministries of health
Definitions and reporting framework for tuberculosis
WHO treatment guidelines for drug-resistant tuberculosis, 2016 update
Hospital onset COVID-19 mortality in Scotland - 7 March 2020 to 31 December 2021
COVID-19 - information and guidance for social, community and residential care settings
Hospital onset COVID-19 cases in Scotland
Pfizer-BioNTech COVID-19 Vaccine (Gray Cap) Age 12 and Over
Schistosomiasis
Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 30 January 2022
WHO Pharmaceuticals Newsletter - N°1, 2022
Vaccination Laws
Caring for those who care: guide for the development and implementation of occupational health and safety programmes for health workers: executive summary
EVA - Explore ECDC's training Catalogue 2022
WHO guideline on health workforce development, attraction, recruitment and retention in rural and remote areas
Health workforce development, attraction, recruitment and retention in rural and remote areas
COVID-19 Resources for Members and Global Public Health Professionals
Treatment and pharmaceutical prophylaxis of COVID-19
Malawi declares polio outbreak
WHO announces the development of new guidance on offering long acting injectable cabotegravir as HIV prevention for people at substantial risk for HIV infection
Pediatric Emergency Department Visits Associated with Mental Health Conditions Before and During the COVID-19 Pandemic — United States, January 2019–January 2022
Measles outbreak training
Scientists pinpoint mechanisms associated with severe COVID-19 blood clotting
Interim Considerations: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination
National Academy of Medicine Launches Fellowship to Advance State Health Policy
COVID-19: reducing outbreak risk with repeated antigen screening in healthcare facilities
Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, July 2021–January 2022
Self-Study Modules on Tuberculosis
Innovative genomic data analysis method leads to the discovery of novel coronavirus families
March 2022 - Emerging Infectious Diseases Journal
WHO updates its treatment guidelines to include molnupiravir
Safety in administering medicines for neglected tropical diseases
COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022
CDC’s Priority to Address Health Equity Issues Across Antibiotic-Resistant Threats
Mental health in emergencies
Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022
Evusheld approved to prevent COVID-19 in people whose immune response is poor
Improving healthcare associated infection surveillance
COVID-19 content collection
Guidelines for prevention and control of Chikungunya fever
Haemophilus influenzae Disease (Including Hib)
Glossary of Health Emergency and Disaster Risk Management Terminology
Notes from the Field: Congenital Varicella Syndrome Case — Illinois, 2021
Manual for case management of cutaneous leishmaniasis in the WHO Eastern Mediterranean Region
World malaria report 2018
Clinical Considerations: Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults
Strengthening Health Services for COVID-19 Response in Kiribati
Pfizer-BioNTech Comirnaty COVID-19 vaccine
Interim Guidance for Infection Control Within Healthcare Settings When Caring for Confirmed Cases, Probable Cases, and Cases Under Investigation for Infection with Novel Influenza A Viruses Associated with Severe Disease
Violent Conflict: The Challenges of Protecting Public Health & Health Care
National Women and Girls HIV/AIDS Awareness Day
Core questions and indicators for monitoring WASH in health care facilities in the Sustainable Development Goals
Effective teaching: a guide for educating healthcare providers
WHO advises that ivermectin only be used to treat COVID-19 within clinical trials
The South-East Asia Region Antimicrobial Stewardship 2022 Webinar Series
Infection
Data collection on COVID-19 outbreaks in closed settings: long-term care facilities, version 2.1
WHO Open Calls for Advisory Groups
WHO PrEP Implementation Tool
The Global Health Observatory
